Dupilumab-Induced Myalgia and Enthesitis in a Pediatric Patient Treated for Severe Atopic Dermatitis

医学 杜皮鲁玛 肌痛 皮肤病科 特应性皮炎 末端炎 中止 皮疹 不利影响 人口 纤维肌痛 痹症科 罪魁祸首
作者
Mohamad Abdulwahab Sabsabee,Alaa Salman,Sheikha Alketbi,Mustafa Al Hamdani,Ali Elsir Musa Nasreldien
出处
期刊:Cureus [Cureus, Inc.]
卷期号:17 (11): e96773-e96773
标识
DOI:10.7759/cureus.96773
摘要

Dupilumab is a monoclonal antibody systemic therapy approved for the treatment of atopic dermatitis (AD). It works by blocking the signaling pathways of interleukin-4 (IL-4) and interleukin-13 (IL-13). This case report describes a 10-year-old male with severe AD who developed myalgia and enthesitis suspected to be induced by dupilumab. The patient developed severe myalgia after a month of being on dupilumab, although his eczematous skin rash showed considerable improvement after treatment initiation. His pain was restricting movement and leading to contractures, which made him unable to walk or stand independently. A thorough diagnostic workup, which included rheumatological, brain, and spine imaging studies, was done to exclude other possible causes. Treatment with dupilumab was stopped, and the patient was advised to undergo physiotherapy and serial casting to restore his muscle function and for the correction of contractures. While dupilumab is regarded as a safe and well-tolerated medication, this report illustrates uncommon adverse effects of the drug that are rarely described in the pediatric population and may contribute to considerable morbidity. A probable underlying mechanism may involve an interaction between the IL-4/IL-13 axis and the IL-17/IL-23 axis, which also play a role in autoimmune arthritis. The report focuses on the significance of close monitoring for musculoskeletal symptoms in patients receiving dupilumab and emphasizes the need for prompt drug discontinuation if such manifestations occur.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
67发布了新的文献求助10
刚刚
秋风的应助被zhangrunbin123采纳,获得10
刚刚
GamAooL发布了新的文献求助10
刚刚
刚刚
1秒前
2秒前
荼蘼发布了新的文献求助10
2秒前
吃猫的鱼发布了新的文献求助10
2秒前
虚心的小兔子完成签到,获得积分10
2秒前
5秒前
小贺完成签到,获得积分10
5秒前
丘比特的应助被哒哒哒采纳,获得10
5秒前
5秒前
6秒前
Lumos完成签到,获得积分10
6秒前
隐形曼青的应助被zzz采纳,获得10
7秒前
7秒前
吃猫的鱼发布了新的文献求助10
7秒前
wang发布了新的文献求助10
8秒前
8秒前
8秒前
单纯的晓刚完成签到,获得积分10
9秒前
看文献就头痛完成签到 ,获得积分10
10秒前
Monster发布了新的文献求助10
10秒前
Quixote完成签到 ,获得积分10
11秒前
12秒前
13秒前
Czz发布了新的文献求助10
14秒前
亵渎完成签到,获得积分10
15秒前
彭于晏的应助被叉叉采纳,获得10
15秒前
荼蘼发布了新的文献求助10
16秒前
16秒前
16秒前
16秒前
美丽冬卉发布了新的文献求助10
17秒前
17秒前
Winy发布了新的文献求助10
17秒前
AZQ完成签到,获得积分10
17秒前
无语完成签到 ,获得积分10
17秒前
顺利的海燕完成签到,获得积分10
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
Resource Recovery Handbook 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8175262
求助须知:如何正确求助?哪些是违规求助? 9567017
关于积分的说明 21789663
捐赠科研通 7769695
什么是DOI,文献DOI怎么找? 3431840
关于科研通互助平台的介绍 2556124
邀请新用户注册赠送积分活动 2477241